
Sign up to save your podcasts
Or


Dr. Mohleen Kang chats with Dr. Aparna Swaminathan and Dr. Timothy Dempsey about their articles, "External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources” and “The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research.”
By American Thoracic Society4
3636 ratings
Dr. Mohleen Kang chats with Dr. Aparna Swaminathan and Dr. Timothy Dempsey about their articles, "External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources” and “The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research.”

1,867 Listeners

139 Listeners

325 Listeners

498 Listeners

64 Listeners

36 Listeners

3,360 Listeners

1,143 Listeners

191 Listeners

698 Listeners

94 Listeners

248 Listeners

249 Listeners

374 Listeners

269 Listeners